C. Costiniuk

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Disentangling Medicinal and Recreational cannabis Use Among People Living with HIV: An Ecological Momentary Assessment Study

P. Shuper, J. Cunningham, C. S. Hendershot, 2022, AIDS and Behavior.

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients

J. Routy, I. Kema, C. Costiniuk, 2016, Journal of acquired immune deficiency syndromes.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic

L. Bélec, C. Costiniuk, J. D. D. Longo, 2017, Medicine.

Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design

Joseph H. Puyat, A. Burchell, A. Anis, 2022, International Journal of Infectious Diseases.

Coronavirus disease 2019 vaccine effectiveness among a population-based cohort of people living with HIV

A. Burchell, R. Moineddin, A. Anis, 2022, AIDS.

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

J. Montaner, M. DeMarco, G. Umviligihozo, 2021, medRxiv : the preprint server for health sciences.

Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2020 .

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

V. Martel-Laferrière, C. Tremblay, C. Chartrand-Lefebvre, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Environmental hazards in Nepal: altitude illness, environmental exposures, injuries, and bites in travelers and expatriates.

K. Kain, A. Boggild, P. Pandey, 2007, Journal of travel medicine.

Cell-to-cell transfer of HIV infection: implications for HIV viral persistence.

C. Costiniuk, M. Jenabian, Mohammad-Ali Jenabian, 2014, The Journal of general virology.

Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic.

C. Kovacs, S. Doucette, C. Costiniuk, 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Pulmonary actinomycosis in a male patient with a tracheal bronchus.

C. Costiniuk, N. Voduc, C. D. de Souza, 2011, Canadian respiratory journal.

HIV reservoir dynamics in the face of highly active antiretroviral therapy.

C. Costiniuk, M. Jenabian, Mohammad-Ali Jenabian, 2015, AIDS patient care and STDs.

ALVAC-HIV as a prophylactic and therapeutic vaccine: highlights from over a decade of clinical trials

J. Angel, C. Costiniuk, 2011 .

HSV-2 Infection as a Potential Cofactor for HIV Disease Progression and Selection of Drug Resistance Mutations in Adults under WHO-Recommended First-Line Antiretroviral Therapy: A Multicentric, Cross-Sectional Study in Cameroon, Central African Republic, Chad, and Gabon

C. Charpentier, F. Mbopi-Kéou, C. Adawaye, 2020, Tropical medicine and infectious disease.

HIV Infection and Persistence in Pulmonary Mucosal Double Negative T Cells In Vivo

E. Haddad, R. Olivenstein, É. Cohen, 2020, Journal of Virology.

SARS-CoV-2 Vaccine-Induced T-Cell Response after Three Doses in People Living with HIV on Antiretroviral Therapy Compared to Seronegative Controls (CTN 328 COVAXHIV Study)

A. Anis, J. Angel, Z. Brumme, 2023, Viruses.

Tackling virological failure in HIV-infected children living in Africa

L. Bélec, T. Brogan, C. Costiniuk, 2015, Expert review of anti-infective therapy.

HIV-HCV Co-infection Therapeutic Outcomes Have Not Improved Over Time

C. Costiniuk, C. Cooper, P. Giguère, 2009, HIV clinical trials.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

C. Tremblay, J. Routy, D. Radzioch, 2015, The Journal of infectious diseases.

Oncolytic Viruses as a Potential Approach to Eliminate the HIV Reservoir

C. Costiniuk, 2013 .

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

A. Vigano, J. Routy, G. Sebastiani, 2022, Biomedicines.

Concurrent HIV viral blips during two episodes of multicentric Castleman disease in an adult on antiretroviral therapy: Implication for HIV persistence

J. Routy, C. Costiniuk, N. Kronfli, 2021, IDCases.

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection

C. Costiniuk, M. Jenabian, Y. Alexandrova, 2022, Frontiers in Immunology.

Surreptitious antiretroviral use as an explanation for apparent elite HIV control.

J. Angel, C. Costiniuk, C. L. la Porte, 2012, AIDS patient care and STDs.

The lungs as anatomical reservoirs of HIV infection

C. Costiniuk, M. Jenabian, Mohammad-Ali Jenabian, 2014, Reviews in medical virology.

PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals

D. Hazuda, S. Lewin, F. Hecht, 2019, Nature Communications.

Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C.

C. Costiniuk, M. Jenabian, Mohammad-Ali Jenabian, 2020, AIDS.

Cannabinoids and inflammation: implications for people living with HIV.

C. Costiniuk, M. Jenabian, 2019 .

Immune tolerance properties of the testicular tissue as a viral sanctuary site in ART-treated HIV-infected adults

J. Routy, R. Bendayan, R. Fromentin, 2016, AIDS.

Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

E. Mills, C. Costiniuk, C. Cooper, 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Neurocognitive and psychiatric changes as the initial presentation of neurosyphilis

C. Costiniuk, P. Macpherson, Cecilia T. Costiniuk, 2013, Canadian Medical Association Journal.

Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian Survey

A. Burchell, C. Kovacs, A. Anis, 2023, AIDS and Behavior.

Short communication: human immunodeficiency virus rebound in blood and seminal plasma following discontinuation of antiretroviral therapy.

J. Singer, C. Kovacs, J. Routy, 2012, AIDS research and human retroviruses.

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross‐sectional study

J. Bourbeau, J. Routy, J. Bourbeau, 2019, HIV medicine.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

J. Singer, J. Routy, M. Brouillette, 2019, BMJ Open.

Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial

S. Murthy, Kevin Schwartz, F. Lamontagne, 2022, Canadian Medical Association Journal.

COVID-19 vaccine immunogenicity in people with HIV

A. Burchell, M. Ostrowski, C. Kovacs, 2022, AIDS.

CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study

J. Singer, A. Burchell, M. Ostrowski, 2021, BMJ Open.

Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment.

R. Olivenstein, N. Chomont, C. Costiniuk, 2019, Journal of visualized experiments : JoVE.

Potential for False-Positive Results with Serological Assays for HIV in Central Africa: Implications for the HIV Serodiagnosis Algorithm According to the 2015 Consolidated WHO Recommendations for Resource-Constrained Countries.

L. Bélec, C. Costiniuk, M. Jenabian, 2017, AIDS research and human retroviruses.

Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054)

Réjean Thomas, C. Costiniuk, M. Jenabian, 2015, HIV clinical trials.

Clinical Practice Guidelines for Cannabis and Cannabinoid-Based Medicines in the Management of Chronic Pain and Co-Occurring Conditions

Z. Walsh, A. Bell, C. Costiniuk, 2023, Cannabis and cannabinoid research.

Primary lung cancer diagnoses in people living with HIV in a large clinical centre in Montreal, Canada over 3 decades

J. Routy, C. Costiniuk, N. Ezer, 2020, AIDS care.

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for a systematic literature review

Z. Walsh, A. Bell, C. Costiniuk, 2020, BMJ Open.

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107

J. Routy, Mélanie Laporte, É. Cohen, 2020, mBio.

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes

Z. Walsh, C. Costiniuk, Shari Margolese, 2023, Journal of Cannabis Research.

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

J. Routy, G. Sebastiani, N. Chomont, 2023, Cells.

Short communication: Lower baseline CD4 count is associated with a greater propensity toward virological failure in a cohort of South African HIV patients.

A. Sigal, C. Costiniuk, M. Jenabian, 2014, AIDS research and human retroviruses.

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)

J. Routy, A. Marette, S. Isnard, 2022, BMJ Open.

Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States

S. Little, S. Gianella, Davey M. Smith, 2023, Journal of virus eradication.

Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy

J. Montaner, M. DeMarco, G. Umviligihozo, 2022, AIDS.

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

C. Tremblay, J. Routy, Réjean Thomas, 2023, BMJ Open.

Antibody and T-cell responses elicited by coronavirus disease 2019 vaccination in people with HIV-1: the case of late presenters

C. Costiniuk, S. Samarani, Ali Ahmad, 2023, AIDS.

Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort

J. Routy, G. Sebastiani, S. Walmsley, 2023, BMJ open.

The Use of CBD and Its Synthetic Analog HU308 in HIV-1-Infected Myeloid Cells

F. Kashanchi, C. Costiniuk, M. Jenabian, 2023, Pharmaceuticals.

Angiocentric lymph proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a case report

J. Routy, J. Karamchandani, C. Costiniuk, 2018, BMC Infectious Diseases.

Trichomonas vaginalis Associated with Chronic Penile Ulcers and Multiple Urethral Fistulas.

C. Costiniuk, M. Moosa, B. Gosnell, 2015, The American journal of tropical medicine and hygiene.

Near full-length HIV sequencing in multiple tissues collected postmortem reveals shared clonal expansions across distinct reservoirs during ART.

J. Routy, R. Fromentin, N. Chomont, 2023, Cell reports.

Coxiella burnetii culture-negative endocarditis diagnosed by 16S rRNA sequencing of heart valve tissue.

B. Wang, C. Costiniuk, B. Toye, 2011, Pathology.

Using different statistical formats for presenting health information

E. Akl, A. Oxman, H. Schünemann, 2007 .

Knowledge of Cannabinoid Content Among People Living with HIV Who Use Cannabis: a Daily Diary Study.

P. Shuper, C. Costiniuk, Shari Margolese, 2023, International journal of behavioral medicine.

A Blast From the Past: Abdominal Wall Amyloidosis Due to Enfuvirtide Injections

A. Bourgault, C. Costiniuk, C. Maedler-Kron, 2023, Cureus.

COVID‐19 vaccine effectiveness by HIV status and history of injection drug use: a test‐negative analysis

A. Burchell, C. Costiniuk, C. Chambers, 2023, Journal of the International AIDS Society.

Framing of health information messages.

E. Akl, A. Oxman, H. Schünemann, 2011, The Cochrane database of systematic reviews.

Preventative behaviours and COVID-19 infection in a Canadian cohort of people living with HIV

A. Burchell, J. Routy, A. Anis, 2023, AIDS Research and Therapy.

Ongoing impact of the social determinants of health during the second and third waves of the COVID-19 pandemic in People Living with HIV receiving care in a Montreal-based Tertiary Care Centre.

J. Routy, C. Costiniuk, C. Frenette, 2022, AIDS research and human retroviruses.

The Influence of Oral Terbinafine on Gut Fungal Microbiome Composition and Microbial Translocation in People Living with HIV Treated for Onychomycosis

J. Routy, S. Isnard, C. Costiniuk, 2023, Journal of fungi.

Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity.

J. Routy, S. Isnard, C. Costiniuk, 2024, Frontiers in immunology.